Bildkälla: Stockfoto

Q-linea Q3: ASTar is ready for the clinic - Redeye

Q-linea's Q3 confirms that Q-linea and its partner Thermo Fisher have secured positive feedback from the initial evaluation. This is also the foundation for the recent launch in the early Q4 quarter (not part of this reported Q3). ASTar has also secured the first formal commercial evaluation contract. So far, so good. Q-linea is executing supported by a strong partner and a solid financial position. Our value proposition is a base of SEK 180 (Bull SEK 230 and Bear SEK 90).

Q-linea's Q3 confirms that Q-linea and its partner Thermo Fisher have secured positive feedback from the initial evaluation. This is also the foundation for the recent launch in the early Q4 quarter (not part of this reported Q3). ASTar has also secured the first formal commercial evaluation contract. So far, so good. Q-linea is executing supported by a strong partner and a solid financial position. Our value proposition is a base of SEK 180 (Bull SEK 230 and Bear SEK 90).
Börsvärldens nyhetsbrev
ANNONSER